I don't know about you guys but I am excited:
The abstract, titled ‘CF33-hNIS, a novel oncolytic virus for the treatment of
cholangiocarcinoma and biliary tract malignancies,’ concludes that CF33-hNIS
monotherapy may be an effective and safe treatment option for GI malignancies,
including cholangiocarcinoma, a rare disease with an unmet medical need.
Spozzie
Ann: Imugene to present at 2024 Cholangiocarcinoma Conference, page-19
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |